Mecsas J - Search Results

1

Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.

Garrity-Ryan LK, Kim OK, Balada-Llasat JM, Bartlett VJ, Verma AK, Fisher ML, Castillo C, Songsungthong W, Tanaka SK, Levy SB, Mecsas J, Alekshun MN. Garrity-Ryan LK, et al. Among authors: mecsas j. Infect Immun. 2010 Nov;78(11):4683-90. doi: 10.1128/IAI.01305-09. Epub 2010 Sep 7. Infect Immun. 2010. PMID: 20823209 Free PMC article.

2

Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Fisher ML, Castillo C, Mecsas J. Fisher ML, et al. Among authors: mecsas j. Infect Immun. 2007 Jan;75(1):429-42. doi: 10.1128/IAI.01287-06. Epub 2006 Oct 30. Infect Immun. 2007. PMID: 17074849 Free PMC article.

3

Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis.

Lister IM, Mecsas J, Levy SB. Lister IM, et al. Among authors: mecsas j. Infect Immun. 2010 Jan;78(1):364-71. doi: 10.1128/IAI.00904-09. Epub 2009 Oct 19. Infect Immun. 2010. PMID: 19841071 Free PMC article.

4

Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system.

Balada-Llasat JM, Mecsas J. Balada-Llasat JM, et al. Among authors: mecsas j. PLoS Pathog. 2006 Sep;2(9):e86. doi: 10.1371/journal.ppat.0020086. PLoS Pathog. 2006. PMID: 16948531 Free PMC article.

5

Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia.

Balada-Llasat JM, Panilaitis B, Kaplan D, Mecsas J. Balada-Llasat JM, et al. Among authors: mecsas j. Vaccine. 2007 Feb 9;25(8):1526-33. doi: 10.1016/j.vaccine.2006.10.016. Epub 2006 Oct 23. Vaccine. 2007. PMID: 17194509

6

The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection.

Durand EA, Maldonado-Arocho FJ, Castillo C, Walsh RL, Mecsas J. Durand EA, et al. Among authors: mecsas j. Cell Microbiol. 2010 Aug;12(8):1064-82. doi: 10.1111/j.1462-5822.2010.01451.x. Epub 2010 Feb 9. Cell Microbiol. 2010. PMID: 20148898 Free PMC article.

7

ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice.

Songsungthong W, Higgins MC, Rolán HG, Murphy JL, Mecsas J. Songsungthong W, et al. Among authors: mecsas j. Cell Microbiol. 2010 Jul;12(7):988-1001. doi: 10.1111/j.1462-5822.2010.01448.x. Epub 2010 Feb 9. Cell Microbiol. 2010. PMID: 20148901 Free PMC article.

8

Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.

Harmon DE, Davis AJ, Castillo C, Mecsas J. Harmon DE, et al. Among authors: mecsas j. Antimicrob Agents Chemother. 2010 Aug;54(8):3241-54. doi: 10.1128/AAC.00364-10. Epub 2010 May 24. Antimicrob Agents Chemother. 2010. PMID: 20498321 Free PMC article.

9

Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection.

Paczosa MK, Fisher ML, Maldonado-Arocho FJ, Mecsas J. Paczosa MK, et al. Among authors: mecsas j. Cell Microbiol. 2014 Feb;16(2):247-68. doi: 10.1111/cmi.12219. Epub 2013 Nov 3. Cell Microbiol. 2014. PMID: 24119087 Free PMC article.

10

Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence.

Lister IM, Raftery C, Mecsas J, Levy SB. Lister IM, et al. Among authors: mecsas j. Antimicrob Agents Chemother. 2012 Feb;56(2):1120-3. doi: 10.1128/AAC.05338-11. Epub 2011 Nov 14. Antimicrob Agents Chemother. 2012. PMID: 22083483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters